Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of METTL3 Results in a Cell-Intrinsic Interferon Response That Enhances Antitumor Immunity
Andrew A. Guirguis, Yaara Ofir-Rosenfeld, Kathy Knezevic, et al.
Cancer Discovery (2023) Vol. 13, Iss. 10, pp. 2228-2247
Closed Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

A new perspective on hematological malignancies: m6A modification in immune microenvironment
Shiyu Yang, Liping Xu, Haihui Zhuang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Peptide degrader‐based targeting of METTL3/14 improves immunotherapy response in cutaneous melanoma
Hong Han, Zenghui Li, Yuqing Feng, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 48
Closed Access | Times Cited: 3
METTL3 inhibitor suppresses the progression of prostate cancer via IGFBP3/AKT pathway and synergizes with PARP inhibitor
Xin Chen, Miaomiao Wang, Haoran Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 179, pp. 117366-117366
Open Access | Times Cited: 3
Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy
Kaixin Wu, Sa Li, Guangliang Hong, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 3
The RNA m6A writer METTL3 in tumor microenvironment: emerging roles and therapeutic implications
Weiqi Su, Lin Che, Wenting Liao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Small molecules that regulate the N6-methyladenosine RNA modification as potential anti-cancer agents
Noah J. Harrahill, M. Kyle Hadden
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116526-116526
Closed Access | Times Cited: 2
Refining the role of N6-methyladenosine in cancer
Jonas Koch, Frank Lyko
Current Opinion in Genetics & Development (2024) Vol. 88, pp. 102242-102242
Open Access | Times Cited: 2
RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints
Xiangyu Qin, Huali Liu, Qixuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
N 6 -methyladenosine modification–tuned lipid metabolism controls skin immune homeostasis via regulating neutrophil chemotaxis
Lian Cui, You Wu, Zeyu Chen, et al.
Science Advances (2024) Vol. 10, Iss. 40
Open Access | Times Cited: 2
SON is an essential m6A target for hematopoietic stem cell fate
Hanzhi Luo, Mariela Cortés-López, Cyrus L. Tam, et al.
Cell stem cell (2023) Vol. 30, Iss. 12, pp. 1658-1673.e10
Closed Access | Times Cited: 6
Epigenetic modulations of immune cells: from normal development to tumor progression
Yuanchun Xu, Zongsheng He, Jing Du, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 16, pp. 5120-5144
Open Access | Times Cited: 4
Navigating the landscape of epitranscriptomics and host immunity
Elaine Huang, Clara Frydman, Xinshu Xiao
Genome Research (2024)
Open Access | Times Cited: 1
The physiological and pathological roles of RNA modifications in T cells
Yu Deng, Jing Zhou, Huabing Li
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1578-1592
Closed Access | Times Cited: 1
GNAS knockout potentiates HDAC3 inhibition through viral mimicry-related interferon responses in lymphoma
Michael Y. He, Kit I. Tong, Ting Liu, et al.
Leukemia (2024) Vol. 38, Iss. 10, pp. 2210-2224
Open Access | Times Cited: 1
Sterile activation of RNA-sensing pathways in autoimmunity
Jiaxin Li, Junyan Zhu, Hui Yang, et al.
Journal of Molecular Cell Biology (2024)
Open Access | Times Cited: 1
Combating cancer stem cells: RNA m6A methylation and small-molecule drug discovery
Honghai Zhang, Xueer Wang, Jianjun Chen, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access | Times Cited: 1
METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma
Ketan Thombare, Roshan Vaid, Perla Pucci, et al.
The EMBO Journal (2024)
Closed Access | Times Cited: 1
RNA sensing induced by chromosome missegregation augments anti-tumor immunity
Nobunari Sasaki, Mizuki Homme, Takahiko Murayama, et al.
Molecular Cell (2024)
Closed Access | Times Cited: 1
METTL3 inhibition enhances anti-tumour immunity
Gabrielle Brewer
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 654-654
Closed Access | Times Cited: 3
Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
Anna Brichkina, Роман В. Суезов, Magdalena Huber
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Functional Impacts of Epitranscriptomic m6A Modification on HIV-1 Infection and Innate Immunity
Tarun Mishra, Stacia Phillips, Siyu Huang, et al.
(2023)
Open Access | Times Cited: 1
SMAD4 Inhibits CXCL1/CXCR2 to Trigger Antitumor Immunity in Colorectal Cancer
Bin Lian, Tingyan Dong, Na You, et al.
Research Square (Research Square) (2024)
Open Access
N6‐Methyladenosine in Mammalian Messenger RNA: Function, Location, and Quantitation
Ruiqi Ge, Mengshu Emily He, Weixin Tang
Israel Journal of Chemistry (2024) Vol. 64, Iss. 3-4
Open Access
FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner
Zhe Yin, Xiong Guo, Xiaolong Liang, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Closed Access
Deficiency of m6A RNA methylation promotes ZBP1-mediated cell death
Shuang Li, Xiangyu Deng, Deepak Pathak, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access

Scroll to top